Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Operating Expenses (2020 - 2025)

Historic Operating Expenses for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $1.6 billion.

  • Agilon Health's Operating Expenses fell 112.63% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 billion, marking a year-over-year increase of 539.57%. This contributed to the annual value of $6.4 billion for FY2024, which is 3966.51% up from last year.
  • Per Agilon Health's latest filing, its Operating Expenses stood at $1.6 billion for Q3 2025, which was down 112.63% from $1.5 billion recorded in Q2 2025.
  • In the past 5 years, Agilon Health's Operating Expenses registered a high of $1.6 billion during Q4 2024, and its lowest value of $177.0 million during Q4 2021.
  • Over the past 5 years, Agilon Health's median Operating Expenses value was $1.1 billion (recorded in 2023), while the average stood at $1.0 billion.
  • As far as peak fluctuations go, Agilon Health's Operating Expenses plummeted by 5094.0% in 2021, and later soared by 18792.68% in 2023.
  • Over the past 5 years, Agilon Health's Operating Expenses (Quarter) stood at $177.0 million in 2021, then surged by 139.48% to $423.8 million in 2022, then skyrocketed by 187.93% to $1.2 billion in 2023, then surged by 33.61% to $1.6 billion in 2024, then decreased by 3.92% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q3 2025, $1.5 billion for Q2 2025, and $1.6 billion during Q1 2025.